Overview
Benign neoplasms of the oral part of the tongue are non-malignant growths that do not invade surrounding tissues and typically do not metastasize 1. These lesions can manifest as various types, including vascular malformations, but the provided abstract focuses specifically on vascular lesions.Diagnosis
Clinical examination is essential for identifying the presence and characteristics of the lesion 1.
Imaging studies (e.g., ultrasound, MRI) may be used to assess lesion extent and vascular nature 1.
Histopathological examination may be necessary for definitive diagnosis, though not specifically addressed in the abstract 1.Management
First-line treatment: Ethanolamine oleate sclerotherapy is highly effective for benign oral vascular lesions 1.
- Doses: 1.25% or 2.5% ethanolamine oleate administered via intralesional injections 1.
- Frequency: Injections repeated every 15 days until complete regression 1.
Lesion size consideration: Smaller lesions (≤20 mm) may require fewer treatments compared to larger ones (>20 mm) 1.Special Populations
No specific data: The provided abstract does not cover management in pregnancy, pediatrics, elderly patients, or those with comorbidities 1.Key Recommendations
Ethanolamine oleate sclerotherapy is recommended for the treatment of benign oral vascular lesions, showing 100% clinical regression 1 (Evidence: Strong).
Lesion size should guide the number of sclerotherapy sessions, with smaller lesions requiring fewer treatments 1 (Evidence: Moderate).
Consider imaging studies to assess lesion extent before initiating sclerotherapy 1 (Evidence: Expert opinion).References
1 Johann AC, Aguiar MC, do Carmo MA, Gomez RS, Castro WH, Mesquita RA. Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: an open clinical trial with 30 lesions. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2005. link